Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

First Edition: January 12, 2010

Today's news coverage details developments related to pending health reform plans with President Obama's meeting with organized labor regarding the 'Cadillac' tax claiming a lot of headlines.

12 Jan 2010

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

GlaxoSmithKline (GSK) and ChemoCentryx, Inc. today announced that GSK has exercised its option to obtain an exclusive license for further development and worldwide commercialization of Traficet-EN(TM) (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including Crohn's disease.

12 Jan 2010

EGS announces improved clinical outcomes from its new TIF procedure

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that data from two single-center series demonstrate improved clinical outcomes from a third-generation technique for its Transoral Incisionless Fundoplication (TIF) procedure. The data includes two case series totaling nearly 70 patients from two independent investigators, Reginald Bell, MD (Swedish Medical Center, Englewood, CO), and William Barnes, MD (Livingston Hospital and Healthcare Services, Inc., Salem, KY).

9 Jan 2010

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

A new national survey reveals that while almost all Canadians understand the importance of getting checked for colon cancer, most have not had a screening test and are confused about how and when it should happen.

8 Jan 2010

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced that it has received a strategic investment from Medtronic, Inc., the global leader in medical device technology and therapies designed to treat chronic diseases.

8 Jan 2010

Prometheus Laboratories executes $260 million senior secured credit facility

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has executed a $260 million senior secured credit facility. The credit facility consists of a $210 million term loan and a $50 million revolving credit line.

7 Jan 2010

Study suggests why circumcised men less likely to become infected with HIV

A PLoS One study published Tuesday sheds new light on why men who have been circumcised are less likely to become infected with HIV, ANI/Times of India reports (1/6).

7 Jan 2010

Findings suggest abuse is a risk factor for chronic headache

Researchers from the American Headache Society's Women's Issues Section Research Consortium found that incidence of childhood maltreatment, especially emotional abuse and neglect, are prevalent in migraine patients.

5 Jan 2010

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Circumcision, which substantially lowers HIV risk in men, also dramatically changes the bacterial communities of the penis, according to a study led by scientists at the Translational Genomics Research Institute (TGen) and Johns Hopkins University and published Jan. 6 in the scientific journal PLoS ONE.

5 Jan 2010

Study confirms link between GI and autism

An article published today in the journal Pediatrics confirms what parents and advocacy organizations have been saying for years: many individuals with autism suffer from gastrointestinal disease that can contribute to behaviors and symptoms associated with autism.

5 Jan 2010

Autism Speaks lauds recommendations for evaluation, diagnosis, and treatment of GI in ASD children

Autism Speaks applauds the consensus statement and recommendations for the evaluation, diagnosis, and treatment of gastrointestinal (GI) disorders in children with autism spectrum disorders (ASD) released online in Pediatrics as one step in advancing physician awareness of unique challenges in the medical management of children with autism.

5 Jan 2010

St. John's wort not effective in treating IBS

A Mayo Clinic research study published in the January issue of the American Journal of Gastroenterology finds that St. John's wort is not an effective treatment for irritable bowel syndrome (IBS). While antidepressants are frequently used to treat IBS, to date, no study has examined the success of using the herbal supplement St. John's wort in treating IBS.

5 Jan 2010

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

In patients with chronic hepatitis C, treatment with peginterferon alpha-2a (PegIFNα2a) plus ribavirin (RBV) better suppresses the virus to undetectable levels in the blood than treatment with peginterferon alpha-2b (PegIFNα2b) plus RBV, according to two new head-to-head studies in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.

5 Jan 2010

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

Robarts Clinical Trials at The University of Western Ontario in London, Canada, has been awarded a 4.7 million dollar grant to conduct a randomized controlled trial evaluating treatment options for Crohn's disease.

5 Jan 2010

EGS receives U.S. patent covering its SerosaFuse fastener and “over the wire” delivery system

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a key patent covering its SerosaFuse fastener and “over the wire” delivery system.

4 Jan 2010

Warner Chilcott accepts $290.5 million in tender offer for its 8-3/4% Senior Subordinated Notes due 2015

Warner Chilcott plc today announced that its subsidiary Warner Chilcott Corporation (the "Company") has received and accepted for purchase approximately $290.5 million aggregate principal amount of its 8-3/4% Senior Subordinated Notes due 2015 (Cusip No. 93443MAC5) (the "Notes") validly tendered by 11:59 p.m., New York City time, on Tuesday, December 29, 2009, (the "Consent Date"), and has received consents from holders of approximately 76% of the Notes as of the Consent Date.

31 Dec 2009

JumpStart announces two JumpStart Ventures investments

JumpStart Inc., the Northeast Ohio venture development organization that accelerates the progress of high growth early-stage businesses, announces two JumpStart Ventures investments.

31 Dec 2009

PDI awarded contract sales engagement with Top 5 pharmaceutical company

PDI, Inc., a leading provider of sales and marketing support to U.S. health care companies, has been awarded a significant contract sales engagement with a Top 5 pharmaceutical company. This program is expected to generate approximately $6 million in revenue for PDI during the first quarter of 2010 and may extend through the remainder of 2010.

24 Dec 2009

Combination of ropivacaine and fibrin sealant is effective in reducing pain after LC procedure

Fibrin sealant has been an extremely effective and widely used adjunct to surgical procedures to control diffuse slow bleeding over large surfaces. In addition, fibrin sealant has been used as a carrier for other compounds. Thus, it has been used to release medicines slowly at a fixed site and is therefore effective for a long time.

23 Dec 2009

Pancreas 3-D imaging useful in preoperative assessment of pancreatic carcinoma patients

In the field of hepatic imaging in the context of living liver donors and before complex partial liver resections, three-dimensional imaging of the liver, hepatic vessels and bile ducts has managed to become established in some centers. In this case, in addition to visualization, the volumetry of various liver sections is of interest. Moreover, the three-dimensional reconstruction can be used preoperatively to consider various resection options and to evaluate their technical feasibility with regard to vascular and bile duct anatomy and to the expected liver volume after surgery.

23 Dec 2009

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

First Edition: January 12, 2010

GSK exercises option to obtain exclusive license to develop and commercialize Traficet-EN

EGS announces improved clinical outcomes from its new TIF procedure

National survey reveals many Canadians understand risk of colon cancer, but are not taking action

Medtronic invests in GI Dynamics to advance treatment for metabolic disorders

Prometheus Laboratories executes $260 million senior secured credit facility

Study suggests why circumcised men less likely to become infected with HIV

Findings suggest abuse is a risk factor for chronic headache

Circumcision lowers HIV risk; changes bacterial community on penis microbiome

Study confirms link between GI and autism

Autism Speaks lauds recommendations for evaluation, diagnosis, and treatment of GI in ASD children

St. John's wort not effective in treating IBS

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

University of Western Ontario receives grant to conduct randomized trial for Crohn's disease

EGS receives U.S. patent covering its SerosaFuse fastener and “over the wire” delivery system

Warner Chilcott accepts $290.5 million in tender offer for its 8-3/4% Senior Subordinated Notes due 2015

JumpStart announces two JumpStart Ventures investments

PDI awarded contract sales engagement with Top 5 pharmaceutical company

Combination of ropivacaine and fibrin sealant is effective in reducing pain after LC procedure

Pancreas 3-D imaging useful in preoperative assessment of pancreatic carcinoma patients

Your full guide to the gut microbiome eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

Your full guide to the gut microbiome eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in